MBP
Myelin basic protein
Also known as: MBP_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P02686
- Gene
- MBP
- Ensembl
- ENSG00000197971
- Chromosome
- 18
- Canonical length
- 304 aa
- Protein class
- Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Plasma membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by the classic MBP gene is a major constituent of the myelin sheath of oligodendrocytes and Schwann cells in the nervous system. However, MBP-related transcripts are also present in the bone marrow and the immune system. These mRNAs arise from the long MBP gene (otherwise called """"""""""""""""""""""""""""""""Golli-MBP"""""""""""""""""""""""""""""""") that contains 3 additional exons located upstream of the classic MBP exons. Alternative splicing from the Golli and the MBP transcription start sites gives rise to 2 sets of MBP-related transcripts and gene products. The Golli mRNAs contain 3 exons unique to Golli-MBP, spliced in-frame to 1 or more MBP exons. They encode hybrid proteins that have N-terminal Golli aa sequence linked to MBP aa sequence. The second family of transcripts contain only MBP exons and produce the well characterized myelin basic proteins. This complex gene structure is conserved among species suggesting that the MBP transcription unit is an integral part of the Golli transcription unit and that this arrangement is important for the function and/or regulation of these genes. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
304 residues, UniProt reviewed canonical sequence.
>P02686|MBP
1 MGNHAGKREL NAEKASTNSE TNRGESEKKR NLGELSRTTS EDNEVFGEAD ANQNNGTSSQ
61 DTAVTDSKRT ADPKNAWQDA HPADPGSRPH LIRLFSRDAP GREDNTFKDR PSESDELQTI
121 QEDSAATSES LDVMASQKRP SQRHGSKYLA TASTMDHARH GFLPRHRDTG ILDSIGRFFG
181 GDRGAPKRGS GKDSHHPART AHYGSLPQKS HGRTQDENPV VHFFKNIVTP RTPPPSQGKG
241 RGLSLSRFSW GAEGQRPGFG YGGRASDYKS AHKGFKGVDA QGTLSKIFKL GGRDSRSGSP
301 MARRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MBP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.69
- Highest tissue expression
- 89,103 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 89,103 nTPM
- midbrain: 42,125 nTPM
- hippocampal formation: 19,948 nTPM
- hypothalamus: 15,746 nTPM
- amygdala: 15,029 nTPM
- basal ganglia: 13,874 nTPM
Single-cell type
- oligodendrocytes: 4,148 nCPM
- neutrophils: 1,796 nCPM
- endometrial glandular cells: 596 nCPM
- cdc: 541 nCPM
- nk-cells: 534 nCPM
- monocytes: 511 nCPM
Immune cell
- neutrophil: 40 nTPM
- eosinophil: 33 nTPM
- memory CD8 T-cell: 28 nTPM
- NK-cell: 28 nTPM
- basophil: 22 nTPM
- gdT-cell: 22 nTPM
Brain region
- medulla oblongata: 46,823 nTPM
- white matter: 43,740 nTPM
- pons: 36,666 nTPM
- spinal cord: 31,402 nTPM
- midbrain: 28,456 nTPM
- basal ganglia: 26,358 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MBP.
Disease | ImmuneIEDB
Conditions an epitope on MBP was assayed in.
- multiple sclerosis B and T cell
- localized scleroderma B cell
- infectious mononucleosis B and T cell
- encephalomyelitis B cell
- autoimmune optic neuritis B cell
- amyotrophic lateral sclerosis B cell
- systemic lupus erythematosus B cell
- autoimmune neuropathy T cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against MBP are reported. Each links to that disease's full target list.
- Multiple Sclerosis 78
- Encephalomyelitis, Autoimmune, Experimental 41
- Hypersensitivity, Delayed 4
- Arthritis, Rheumatoid 3
- Peripheral Nervous System Diseases 3
- Schizophrenia 3
- Stroke 3
Showing 7 of 11 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for MBP from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
201 publications
- Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event.
2003 · N Engl J Med · RCR 9.8 · 446 citations - Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments.
1988 · J Immunol · RCR 8.4 · 391 citations - Interleukin-10 prevents experimental allergic encephalomyelitis in rats.
1994 · Eur J Immunol · RCR 8.1 · 341 citations - Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
1999 · Brain · RCR 6.1 · 269 citations - Antibodies to myelin basic protein in children with autistic behavior.
1993 · Brain Behav Immun · RCR 5.9 · 193 citations
Show 20 more of 201 total
- Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy.
2006 · Biol Psychiatry · RCR 4.9 · 181 citations - Immunological findings in autism.
2005 · Int Rev Neurobiol · RCR 4.8 · 182 citations - Neuro-Behçet's disease: an update of clinical diagnosis, biomarkers, and immunopathogenesis.
2025 · Clin Exp Immunol · RCR 4.6 · 12 citations - CSF antibody to myelin basic protein. Measurement in patients with multiple sclerosis and subacute sclerosing panencephalitis.
1980 · Arch Neurol · RCR 4.4 · 137 citations - Air pollution and children: neural and tight junction antibodies and combustion metals, the role of barrier breakdown and brain immunity in neurodegeneration.
2015 · J Alzheimers Dis · RCR 4.4 · 105 citations - Lack of association between antimyelin antibodies and progression to multiple sclerosis.
2007 · N Engl J Med · RCR 4.3 · 178 citations - Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination.
1987 · N Engl J Med · RCR 4 · 127 citations - Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes.
1997 · J Clin Invest · RCR 3.7 · 172 citations - Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendrocyte glycoprotein.
1990 · J Neurochem · RCR 3.6 · 139 citations - Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease.
2019 · J Autoimmun · RCR 3.5 · 63 citations - Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis.
1990 · Ann Neurol · RCR 3.1 · 123 citations - Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism.
1998 · Clin Immunol Immunopathol · RCR 3 · 100 citations - Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats.
1994 · J Immunol · RCR 2.5 · 111 citations - Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells.
1995 · J Exp Med · RCR 2.5 · 128 citations - Sera of glaucoma patients show autoantibodies against myelin basic protein and complex autoantibody profiles against human optic nerve antigens.
2008 · Graefes Arch Clin Exp Ophthalmol · RCR 2.4 · 80 citations - Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis.
2008 · J Immunol · RCR 2.3 · 93 citations - Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatment.
2006 · Eur J Neurol · RCR 2.2 · 109 citations - CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies.
1983 · Acta Neurol Scand · RCR 2.2 · 81 citations - Catalytic Antibodies May Contribute to Demyelination in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
2024 · Biochemistry · RCR 2 · 9 citations - Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients.
2014 · J Neuroimmunol · RCR 1.9 · 53 citations
Reference: B cellIEDB
15 publications
- Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis.
2003 · Ann Neurol · RCR 3.5 · 163 citations - High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.
2016 · Mol Cell Proteomics · RCR 2.5 · 66 citations - Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis.
2008 · J Immunol · RCR 2.3 · 93 citations - Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients.
2014 · J Neuroimmunol · RCR 1.9 · 53 citations - Human myelin basic protein peptide 69-89: immunochemical features and use in immunoassays of cerebrospinal fluid.
1988 · J Neuroimmunol · RCR 0.8 · 24 citations
Show 10 more
- Multiple sites of the cleavage of 21- and 25-mer encephalytogenic oligopeptides corresponding to human myelin basic protein (MBP) by specific anti-MBP antibodies from patients with systemic lupus erythematosus.
2013 · PLoS One · RCR 0.7 · 18 citations - IgG reactivity against citrullinated myelin basic protein in multiple sclerosis.
2001 · J Neuroimmunol · RCR 0.7 · 30 citations - Increased synthetic peptide specificity of tissue-CSF bound anti-MBP in multiple sclerosis.
1993 · J Neuroimmunol · RCR 0.7 · 24 citations - Immune response induced by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides in current and past infectious mononucleosis: a risk for multiple sclerosis?
2016 · Eur J Neurol · RCR 0.6 · 12 citations - Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid.
1992 · J Neuroimmunol · RCR 0.5 · 18 citations - B-cell responses to myelin basic protein and its epitopes in autoimmune encephalomyelitis induced by Semple rabies vaccine.
1999 · J Neuroimmunol · RCR 0.3 · 10 citations - Optic neuritis anti-myelin basic protein synthetic peptide specificity.
1992 · J Neurol Sci · RCR 0.2 · 7 citations - Autoantigen microarrays reveal myelin basic protein autoantibodies in morphea.
2022 · J Transl Med · RCR 0.2 · 1 citations - Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis.
2013 · J Neuroimmunol · RCR 0.1 · 4 citations - Apheresis for the treatment of relapses in MS and NMOSD: reduced antibody reactivities, gene expression changes and potential clinical response indicators.
2025 · Front Immunol
Reference: T cellIEDB
53 publications
- EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation.
2026 · Cell · RCR 15 · 15 citations - Deconstructing the peptide-MHC specificity of T cell recognition.
2014 · Cell · RCR 10.7 · 457 citations - HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis.
2020 · Cell · RCR 9.4 · 213 citations - Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8(+) T Lymphocytes.
2015 · Immunity · RCR 6.4 · 266 citations - Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis.
2013 · Sci Transl Med · RCR 6.3 · 238 citations
Show 20 more of 53 total
- Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals.
1990 · J Immunol · RCR 6.2 · 313 citations - Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors.
1990 · Proc Natl Acad Sci U S A · RCR 5.8 · 294 citations - Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
1993 · J Clin Invest · RCR 3.9 · 196 citations - Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis.
2004 · J Immunol · RCR 3.6 · 198 citations - Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.
2018 · J Autoimmun · RCR 3 · 96 citations - Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides.
1994 · Proc Natl Acad Sci U S A · RCR 3 · 137 citations - GDP-l-fucose synthase is a CD4+ T cell-specific autoantigen in DRB3*02:02 patients with multiple sclerosis.
2018 · Sci Transl Med · RCR 2.5 · 79 citations - MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes.
1998 · J Immunol · RCR 2.4 · 120 citations - Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells.
2009 · Clin Immunol · RCR 2.2 · 100 citations - Brain Citrullination Patterns and T Cell Reactivity of Cerebrospinal Fluid-Derived CD4+ T Cells in Multiple Sclerosis.
2019 · Front Immunol · RCR 2.2 · 45 citations - Response of human T lymphocyte lines to myelin basic protein: association of dominant epitopes with HLA class II restriction molecules.
1989 · J Neurosci Res · RCR 2.1 · 101 citations - Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis.
2004 · J Immunol · RCR 2.1 · 111 citations - Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis.
1992 · Eur J Immunol · RCR 2 · 97 citations - T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls.
2001 · J Neurosci Res · RCR 2 · 109 citations - Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome.
2011 · Brain · RCR 2 · 75 citations - T-Cell Specificity Influences Disease Heterogeneity in Multiple Sclerosis.
2021 · Neurol Neuroimmunol Neuroinflamm · RCR 2 · 33 citations - Antigen identification for HLA class I- and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells.
2021 · Sci Immunol · RCR 1.8 · 40 citations - T cell responses to myelin basic protein in patients with spinal cord injury and multiple sclerosis.
1999 · J Neuroimmunol · RCR 1.7 · 69 citations - Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire.
1997 · J Clin Invest · RCR 1.5 · 86 citations - T cell response to myelin basic protein epitopes in multiple sclerosis patients and healthy subjects.
1991 · Eur J Immunol · RCR 1.4 · 72 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.79
- gnomAD pLI
- 0.28
- gnomAD missense Z
- 0.6
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axon ensheathment
- central nervous system development
- chemical synaptic transmission
- immune response
- membrane organization
- myelin assembly
- myelination
- response to toxic substance
- sensory perception of sound
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Myelin basic protein
- Myelin basic protein
KeywordsUniProt
- Acetylation
- Cell membrane
- Citrullination
- Membrane
- Methylation
- Nucleus
- Phosphoprotein
- Autoimmune encephalomyelitis
InteractionsUniProt · HPA
Protein binding partners of MBP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MBP as an antibody target. Whether an autoantibody or antibody against MBP could matter depends on whether native MBP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MBP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- Autoimmune encephalomyelitis
Loading the interactive Seroatlas protein explorer...